Cost of treatment in a US commercially insured, HIV-1-infected population.

Recent treatment patterns and cost data associated with HIV in the United States are limited. This study assessed first-line persistence and healthcare costs of HIV-1 in patients by treatment line and CD4 cell count.MarketScan Commercial Claims and Encounters Database (2007-2011) and Lab Database (2...

Full description

Bibliographic Details
Main Authors: Caitlyn T Solem, Sonya J Snedecor, Alexandra Khachatryan, Katherine Nedrow, Margaret Tawadrous, Richard Chambers, Seema Haider, Kit Simpson
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4035292?pdf=render